Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Adherence to Antihypertensive Therapy.

Peacock E, Krousel-Wood M.

Med Clin North Am. 2017 Jan;101(1):229-245. doi: 10.1016/j.mcna.2016.08.005. Review.

PMID:
27884232
2.

Adherence to therapy for Barrett's esophagus-associated neoplasia.

Cassani L, Slaughter JC, Yachimski P.

United European Gastroenterol J. 2016 Feb;4(1):42-8. doi: 10.1177/2050640615585469. Epub 2015 May 5.

3.

Trends in health care expenditure in U.S. adults with diabetes: 2002-2011.

Ozieh MN, Bishu KG, Dismuke CE, Egede LE.

Diabetes Care. 2015 Oct;38(10):1844-51. doi: 10.2337/dc15-0369. Epub 2015 Jul 22.

4.

A Systematic Review of Interventions Addressing Adherence to Anti-Diabetic Medications in Patients with Type 2 Diabetes--Components of Interventions.

Sapkota S, Brien JA, Greenfield JR, Aslani P.

PLoS One. 2015 Jun 8;10(6):e0128581. doi: 10.1371/journal.pone.0128581. eCollection 2015 Jun 8. Review.

5.

A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 diabetes--impact on adherence.

Sapkota S, Brien JA, Greenfield J, Aslani P.

PLoS One. 2015 Feb 24;10(2):e0118296. doi: 10.1371/journal.pone.0118296. eCollection 2015 Feb 24. Review.

6.

Pharmaceutical Cost-Saving Strategies and their Association with Medication Adherence in a Medicare Supplement Population.

Musich S, Cheng Y, Wang SS, Hommer CE, Hawkins K, Yeh CS.

J Gen Intern Med. 2015 Aug;30(8):1208-14. doi: 10.1007/s11606-015-3196-7. Epub 2015 Feb 10.

7.

Medication adherence and readmission after myocardial infarction in the Medicare population.

Zhang Y, Kaplan CM, Baik SH, Chang CC, Lave JR.

Am J Manag Care. 2014;20(11):e498-505.

8.

Adherence to antihypertensive medications: is prescribing the right pill enough?

Gosmanova EO, Kovesdy CP.

Nephrol Dial Transplant. 2015 Oct;30(10):1649-56. doi: 10.1093/ndt/gfu330. Epub 2014 Oct 21. Review.

9.

Association between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: a systematic review.

Mann BS, Barnieh L, Tang K, Campbell DJ, Clement F, Hemmelgarn B, Tonelli M, Lorenzetti D, Manns BJ.

PLoS One. 2014 Mar 25;9(3):e89168. doi: 10.1371/journal.pone.0089168. eCollection 2014 Mar 25. Review.

10.

Race/Ethnicity, disability, and medication adherence among medicare beneficiaries with heart failure.

Zhang Y, Baik SH.

J Gen Intern Med. 2014 Apr;29(4):602-7. doi: 10.1007/s11606-013-2692-x. Epub 2013 Dec 24.

11.

Effects of Medicare Part D coverage gap on medication adherence.

Zhang Y, Baik SH, Lave JR.

Am J Manag Care. 2013 Jun 1;19(6):e214-24.

12.
13.

Cost-effectiveness of Medicare drug plans in schizophrenia and bipolar disorder.

Smith KJ, Baik SH, Reynolds CF 3rd, Rollman BL, Zhang Y.

Am J Manag Care. 2013 Feb 1;19(2):e55-63.

14.

Medicare Part D and potentially inappropriate medication use in the elderly.

Donohue JM, Marcum ZA, Gellad WF, Lave JR, Men A, Hanlon JT.

Am J Manag Care. 2012 Sep 1;18(9):e315-22.

15.

The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure.

Baik SH, Rollman BL, Reynolds CF 3rd, Lave JR, Smith KJ, Zhang Y.

J Ment Health Policy Econ. 2012 Sep;15(3):105-18.

16.

Disability, race/ethnicity, and medication adherence among Medicare myocardial infarction survivors.

Zhang Y, Baik SH, Chang CC, Kaplan CM, Lave JR.

Am Heart J. 2012 Sep;164(3):425-433.e4. doi: 10.1016/j.ahj.2012.05.021. Epub 2012 Aug 3.

17.

Ethnic disparities in adherence to antihypertensive medications of medicare part D beneficiaries.

Holmes HM, Luo R, Hanlon JT, Elting LS, Suarez-Almazor M, Goodwin JS.

J Am Geriatr Soc. 2012 Jul;60(7):1298-303. doi: 10.1111/j.1532-5415.2012.04037.x. Epub 2012 Jun 15.

18.

Medicare Part D and quality of prescription medication use in older adults.

Lau DT, Briesacher BA, Touchette DR, Stubbings J, Ng JH.

Drugs Aging. 2011 Oct 1;28(10):797-807. doi: 10.2165/11595250-000000000-00000. Review.

19.

Medicare Part D's effect on the under- and overuse of medications: a systematic review.

Polinski JM, Donohue JM, Kilabuk E, Shrank WH.

J Am Geriatr Soc. 2011 Oct;59(10):1922-33. doi: 10.1111/j.1532-5415.2011.03537.x. Epub 2011 Aug 1. Review.

20.

Drug benefit changes under Medicare Advantage Part D: heterogeneous effects on pharmaceutical use and expenditures.

Ettner SL, Steers WN, Turk N, Quiter ES, Mangione CM.

J Gen Intern Med. 2011 Oct;26(10):1195-200. doi: 10.1007/s11606-011-1766-x. Epub 2011 Jun 28.

Supplemental Content

Support Center